Original Research
Published on 01 Jul 2025
Interpreting immune evasion: a novel assay for HLA loss detection
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1603188
- 327 views
Type at least 3 characters
1,710 articles
Original Research
Accepted on 30 Jun 2025
Unveiling new horizons in severe aplastic anemia management: A two-decade study on intensive immunosuppressive therapy combined with unrelated cord blood efficacy
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1622326
Clinical Trial
Accepted on 30 Jun 2025
Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1617589
Original Research
Accepted on 27 Jun 2025
Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center, real-world experience
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1621708
- 110 views
Original Research
Published on 26 Jun 2025
Optimized multiplex PCR-NGS for comprehensive HLA genotyping in Chinese populations: resolving ambiguities at high resolution
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1551173
- 616 views
Correction
Published on 26 Jun 2025
Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1633590
- 160 views
Case Report
Published on 26 Jun 2025
Case Report: dose adjustment of orelabrutinib for managing central nervous system post-transplant lymphoproliferative disorder following acute lymphoblastic leukemia transplantation
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1597119
- 283 views
Original Research
Published on 24 Jun 2025
Donor-derived cell-free DNA and miRNA monitoring for the early prediction and diagnosis of liver allograft rejection and patient outcomes
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1604200
- 436 views
Review
Accepted on 23 Jun 2025
Breaking boundaries in ankylosing spondylitis: how innovative cell therapies reshape immunity, drive cutting-edge advances, and face future challenges
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1613502
- 116 views
Systematic Review
Accepted on 23 Jun 2025
Comparative Efficacy and Safety of Induction Therapy in Solid Organ Transplantation：A Systematic Review and Network Meta-analysis
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1625710
Original Research
Accepted on 23 Jun 2025
A Higher Ratio of IL-2/IL-4 may be an Early Predictor of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1620761
Original Research
Published on 23 Jun 2025
Kidney transplant outcomes in HLA desensitized patients with pretransplant CDC and/or FCM positive crossmatches
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1612462
- 358 views
Review
Accepted on 19 Jun 2025
What are the functional outcomes of total laryngeal transplantation? -A systematic review of preclinical and clinical studies
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1631525
- 108 views
Original Research
Published on 19 Jun 2025
Persistent lymphopenia after kidney transplantation: increased mortality and decreased homeostatic mechanisms
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1605794
- 500 views
Original Research
Accepted on 18 Jun 2025
Impact of Pre-transplant Body Mass Index on Outcomes in AML Patients Aged ≥ 50 Years After Allogeneic Hematopoietic Cell Transplantation
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1586523
Original Research
Published on 18 Jun 2025
Evaluating the immunogenicity of a mouse partial hindlimb for composite allotransplantation
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595319
- 503 views